- Home
- RIGL vs KRO Comparison
RIGL vs KRO Comparison
Compare RIGL & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIGL | KRO |
|---|---|---|
| Founded | 1996 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.4M | 604.0M |
| IPO Year | 2000 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RIGL | KRO |
|---|---|---|
| Price | $34.56 | $5.82 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.20 | $6.00 |
| AVG Volume (30 Days) | ★ 257.9K | 257.4K |
| Earning Date | 04-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ 807.14 | 274.42 |
| EPS | ★ 5.38 | N/A |
| Revenue | $179,278,000.00 | ★ $1,887,100,000.00 |
| Revenue This Year | $66.81 | N/A |
| Revenue Next Year | N/A | $5.02 |
| P/E Ratio | $6.66 | ★ N/A |
| Revenue Growth | ★ 53.38 | 13.24 |
| 52 Week Low | $15.50 | $4.08 |
| 52 Week High | $52.24 | $8.93 |
Technical Indicators
Market Signals| Indicator | RIGL | KRO |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 49.19 |
| Support Level | $33.05 | $5.14 |
| Resistance Level | $36.95 | $6.74 |
| Average True Range (ATR) | 1.46 | 0.30 |
| MACD | 0.24 | -0.10 |
| Stochastic Oscillator | 39.78 | 23.21 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.